Efficacy of Itraconazole in the Prevention of Fungal Infections Among Neutropenic Patients with Hematologic Malignancies and Intensive Chemotherapy. A Double Blind, Placebo Controlled Study

References

• De Gregorio M. W., Lee W. M. F., Linker C. A., Jacobs R. A., Ries C. A. Fungal infections in patients with acute leukemia. Am. J. Med. 1982; 73: 543–548
   PubMed Web of Science ®Google Scholar
• Martino P., Girmenia C., Venditti M., et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 1989; 64: 2030–2034
   PubMed Web of Science ®Google Scholar
• Verfaillie C, Weisdorf R., Haake R., Hostetter M., Ramsay N. K. C., McGlave P. Candida infections in bone marrow transplant recipients. Bone Marrow Transplant. 1991; 8: 177–184
   PubMed Web of Science ®Google Scholar
• Medoff G., Kobayashi G. S. Strategies in the treatment of systemic fungal infections. N. Eng. J. Med. 1980; 302: 145–155
   PubMed Web of Science ®Google Scholar
• Gallis H. A., Drew R. H., Pickard W. W. Am-photericin-B: 30 years of clinical experience. Rev. Infectious Diseases 1990; 12: 308–329
   PubMedGoogle Scholar
• Meunier F. Fungal infections in the immunocompro-mised host. Clinical Approach to Infection in the Immu-nocompromised Host, R. H. Rubin, L. S. Young. Plenum Publishing, New York 1988; 193–220
   Google Scholar
• Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida Kru-sei infection among patients with bone marrow transplantation and neutropenia treated prophytactically with fluconazole. N. Eng. J. Med. 1991; 325: 1274–1277
   PubMed Web of Science ®Google Scholar
• DeGregorio M. W., Lee W. M. F., Ries C. A. Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between or-opharyngeal and systemic candidiasis. Cancer 1982; 50: 2780–2784
   PubMed Web of Science ®Google Scholar
• Gunther I., Kaben U., Dunker H., Brijmohan-Gunther R., Konrad H. Selective decontamination of the digestive tract and fungal infection in acute leukemia patients. Recent Results Cancer Res. 1988; 108: 83–88
   Google Scholar
• Rousey S. R., Russler S., Gottlieb M., Ash R. C. Low-dose amphotericin B prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation. Am. J. Med. 1991; 91: 484–492
   PubMed Web of Science ®Google Scholar
• Donnelly J. P., Starke I. D., Galton D. A. G., Catovsky D., Goldman J. M., Darrell J. H. Oral ketocon-azole and amphotericin B for the prevention of yeast colonization in patients with acute leukemia. J. Hasp. Infect. 1984; 5: 83–91
   PubMed Web of Science ®Google Scholar
• Benhamou E., Hartmann O., Nogues C., Maraninchi D., Valteau D., Lemerle J. Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo controlled trial. Bone Marrow Transplant. 1991; 7: 127–131
   PubMed Web of Science ®Google Scholar
• Jones P. G., Kauffmann C. A., McAuliffe L. S., Liepman M. K., Bergman A. G. Efficacy of ketoconazole versus nystatin in prevention of fungal infections in neutropenic patients. Arch. Int. Med. 1984; 144: 549–551
   PubMed Web of Science ®Google Scholar
• Shepp D. H., Klosterman A., Siegel M. S., Meyers J. D. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. J. Infectious Diseases 1985; 22: 1257–1263
   Google Scholar
• Hansen R. M., Reinerio N., Sohnle P. G., Abrams R. A., Ritch P. S., Libnoch J. A., Anderson T. Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective randomized controlled double blind study. Arch. Int. Med. 1987; 147: 710–712
   PubMed Web of Science ®Google Scholar
• Goodman J. L., Winston D. J., Greenfield R. A., et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Eng. J. Med. 1992; 326: 845–851
   PubMed Web of Science ®Google Scholar
• Troke P. F., Andrews R. J., Marriott M. S., Richardson K. Efficacy of fluconazole (UK 49858) against experimental aspergillosis and cryptococcosis in mice. J. An-timicrob. Chemother. 1987; 19: 663–670
   PubMed Web of Science ®Google Scholar
• Van Cutsem J., Van Gerven F., Van de Ven M., Borgers M., Janssen P. A. J. Itraconazole, a new triazole that is orally effective in aspergillosis. Antimicrob. Agents Chemother. 1984; 26: 527–534
   PubMed Web of Science ®Google Scholar
• Van Cutsem J., Fransen F., Janssen P. A. J. Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs. Chemotherapy 1987; 33: 52–60
   PubMed Web of Science ®Google Scholar
• Van't Wout J. W., Novakova I., Verhagen C. A. H., Fibbe W. E., De Pauw B. E., Van der Meer J. W. M. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J. Infect. 1991; 2: 45–52
   Web of Science ®Google Scholar
• Prentice A. G., Bradford G. R. Prophylaxis of fungal infections with itraconazole during remission induction therapy. Mycoses 1989; 32(Supp)96–102
   PubMedGoogle Scholar
• Boogaerts M. A., Verhoef G. E., Zachee P., Demuynck H., Verbist L., De Beule K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Mycoses 1989; 32(Supp)103–108
   PubMedGoogle Scholar
• Thunnissen P. L. M., Sizoo W., Hendriks W. D. H. Safety and efficacy in prevention of fungal infections in neutropenic patients. Netherlands J. Med. 1991; 39: 84–91
   PubMed Web of Science ®Google Scholar
• Tricot G., Joosten E., Boogaerts M. A., Vande Pitte J., Cauwenbergh G. Ketoconazole versus itraconazole for prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Infectious Diseases 1987; 9(Supp)S94–S99
   Google Scholar
• Sugar A. M. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use. Arch. Int. Med. 1990; 150: 2258–2264
   PubMed Web of Science ®Google Scholar
• Bodey G. P. Fungal infection and fever of unknown origin in neutropenic patients. Am. J. Med. 1986; 80(Supp. 5c)112–1199
   PubMed Web of Science ®Google Scholar
• Novakova [., Donnelly J. P., De Pauw B. E. Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment for presumed bacteremia in febrile granulocytopenic patients. Antimicrob. Agents Chemother. 1991; 35: 672–678
   PubMed Web of Science ®Google Scholar
• Dismukes W. E., Bradsher R. W., Cloud G. C., et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am. J. Med. 1992; 93: 489–497
   PubMed Web of Science ®Google Scholar
• Denning D. W., Tucker R. M., Hanson L. H., Stevens D. A. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 1989; 86: 791–800
   PubMed Web of Science ®Google Scholar
• Viviani M. A., Tortorano A. M., Langer M., et al. Experience with itraconazole in cryptococcosis and aspergillosis. J. Infection 1989; 18: 151–165
   PubMed Web of Science ®Google Scholar
• Heykants J., Van Peer A., Van de Velde V., et al. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1989; 32(Supp. 1)67–87
   PubMedGoogle Scholar
• Rozenberg-Arska M., Dekker A. W., Branger J., Verhoef J. A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukemia. J. Antimicrob. Chemother. 1991; 27: 369–376
   PubMed Web of Science ®Google Scholar